Cipla Limited has announced key organizational updates following its board meeting on May 13, 2026. The company has approved the appointment of Mr. Sushrut Kulkarni as President and Global Chief of Integrated Product Development and selected M/s Joshi Apte & Associates as Cost Auditors for the upcoming fiscal year. Additionally, the Board has authorized new employee stock option grants and finalized the date for the 90th Annual General Meeting.
Leadership and Governance Updates
Cipla has bolstered its senior management team with the appointment of Mr. Sushrut Kulkarni as President & Global Chief – Integrated Product Development (IPD), effective May 18, 2026. Mr. Kulkarni brings three decades of experience to the company, previously serving at Dr. Reddy’s Laboratories and other major pharmaceutical firms. Alongside this appointment, the board has designated M/s Joshi Apte & Associates to serve as the company’s Cost Auditors for the 2026-27 financial year.
Employee Stock Incentive Program
To align employee interests with long-term growth, the Board has approved the issuance of stock options and employee stock appreciation rights (ESARs). These grants are issued under the ESOS 2013-A and ESAR 2021 schemes. The stock options carry an exercise price of INR 2 per unit, with vesting schedules spanning from 1 to 3 years and an exercise window of 5 years from the date of vesting.
Annual General Meeting Scheduled
The company has officially scheduled its 90th Annual General Meeting to be held on Thursday, June 25, 2026. This milestone event will bring together the company’s leadership and shareholders to discuss the strategic direction and performance of the organization.
Source: BSE
